Healthcare -
Biotechnology - NASDAQ - US
$ 1.05
2.94 %
$ 57.8 M
Market Cap
-0.59
P/E
PRLD - CHANGE IN WORKING CAPITAL
Change in Working Capital PRLD - Prelude Therapeutics Incorporated
-10.5 M
LAST VALUE
-97.25%
2 YEAR CAGR
-53.72%
5 YEAR CAGR
0.00%
10 YEAR CAGR